Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The humanoid robot sector has experienced significant fluctuations, with a notable decline of 8.73% in the core company index, underperforming the CSI 300 index which saw a slight increase of 0.08% [11][12] - Tesla's CEO Elon Musk emphasized the acceleration of humanoid robot production, aiming for a capacity of 1 million units at the Fremont factory by 2026, marking a pivotal shift towards mass production [12][18] - The report highlights the potential of the humanoid robot industry to enter a "golden decade" as production ramps up from 2025 to 2026, transitioning from initial development to mass deployment [12][18] Summary by Sections Section 1: Market Overview - The humanoid robot sector has faced a significant downturn, with individual stocks showing varied performance, including notable declines for companies like Longsheng Technology and Weichuang Electric [11][12] - The overall market sentiment is affected by short-term catalysts such as factory audits and Tesla's earnings call, alongside seasonal shifts in investment preferences as the Chinese New Year approaches [12] Section 2: Space Mining and Robotics - China is advancing its space resource development strategy, focusing on key technologies for asteroid resource exploration and intelligent autonomous mining [18][19] - The report identifies the challenges of space mining, including microgravity and high radiation environments, which necessitate advanced robotic technologies [20][26] - Humanoid robots and other multifunctional robots are expected to play a crucial role in space mining operations, capable of performing various tasks in extreme conditions [20][35] Section 3: Beneficiary Segments - The commercial space sector is poised for growth, driven by policy support and increasing demand for satellite launches and networks [41] - Key beneficiaries in the humanoid robot and commercial space sectors include companies involved in core components, structural parts, and specialized robotics [42] - The report lists specific companies that are expected to benefit from advancements in humanoid robotics and space mining technologies, including Blue Sky Technology and Junsheng Electronics [42]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the emergence of HBN, a leading domestic skincare brand, which has submitted its prospectus to the Hong Kong Stock Exchange, indicating strong growth potential in the efficacy skincare market [3][24] - The report emphasizes the importance of emotional consumption themes and recommends high-quality companies in high-growth sectors, including gold and jewelry, offline retail, cosmetics, and medical aesthetics [6][49] Summary by Sections Retail and Social Services Market Review - For the week of January 26 to January 30, the retail and social services indices closed at 2435.34 points and 9283.84 points, respectively, with declines of 4.18% and 3.45% [5][14] - The jewelry sector showed the highest growth, with a weekly increase of 7.07% and a year-to-date increase of 19.39% [15][18] Industry Dynamics: HBN and Efficacy Skincare - HBN, established in 2019, is the largest domestic skincare brand in the efficacy segment, focusing on visible results and innovative product strategies [24][25] - The brand's core products, including the "A Retinol" series, have achieved significant sales milestones, with a strong emphasis on scientific validation and consumer trust [29][33] Investment Recommendations - Investment focus areas include: - Gold and jewelry brands with differentiated product offerings, recommending companies like Laopuhuang and Chaohongji [6][49] - Offline retail companies adapting to market changes, with recommendations for Yonghui Supermarket and Aiyingshi [6][49] - Domestic cosmetics brands that emphasize emotional value and safety, recommending brands like Maogeping and Proya [6][50] - Medical aesthetics firms with unique product lines, recommending Meilitiantian Medical Health and Aimeike [6][51]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to achieve a net profit attributable to shareholders of 1.67 to 1.85 billion yuan for 2025, representing a year-on-year increase of 54% to 71%. The non-recurring net profit is projected to be 1.62 to 1.79 billion yuan, also showing a year-on-year increase of 53% to 69%. For Q4 2025, the net profit is expected to be between -117 million to 63 million yuan, reflecting a year-on-year decline of 202% to 45% due to increased income tax and exchange losses. The profit forecast for 2025-2027 has been adjusted downwards, with expected net profits of 1.759 billion, 2.316 billion, and 2.954 billion yuan respectively, corresponding to EPS of 24.42, 32.15, and 41.00 yuan. The current stock price corresponds to P/E ratios of 21.2, 16.1, and 12.6 times for the respective years. The company is expected to maintain double-digit growth in its two-wheeler segment and stable profitability due to increased APP profits and ongoing channel optimization [5][7]. Financial Summary - The company’s revenue is projected to grow significantly, with expected revenues of 21.403 billion yuan in 2025, 29.132 billion yuan in 2026, and 37.117 billion yuan in 2027, reflecting year-on-year growth rates of 50.8%, 36.1%, and 27.4% respectively. The gross margin is expected to improve to 30.3% in 2025 and further to 31.4% in 2026. The net profit margin is projected to be 8.2% in 2025 and 7.9% in 2026. The return on equity (ROE) is expected to reach 22.1% in 2025 and 23.5% in 2026 [8][10]. Product Performance - In Q4 2025, the two-wheeler segment is expected to focus on inventory clearance, with an estimated shipment of 4.1 million units for the year and 200,000 to 300,000 units for Q4, showing a decline due to policy changes. However, the average selling price is expected to increase. The all-terrain vehicle segment is anticipated to continue its growth in non-US regions, while the lawn mower segment is expected to exceed expectations due to low inventory levels [6][7]. Growth Outlook - For 2026, the two-wheeler segment is expected to outperform industry growth, with a target of 30% volume increase driven by electric motorcycles and low inventory. The lawn mower segment is projected to double its revenue, supported by the release of nine new SKUs and channel deepening. The E-Bike segment is also expected to show strong growth potential following positive feedback from product launches [7][8].

2026 年 02 月 01 日 策略研究团队 再提"坚定牛市信心，降低预期斜率" 本周市场整体仍处在整理态势中，但板块与个股却有波澜壮阔的极致反馈，如白 酒板块于周中异动大涨，周内成交火热的有色板块于最后一个交易日出现大幅回 撤，给市场带来了一定的恐慌。这也反映出：其一市场频繁且相对极致的轮动表 现很大程度上增加了追涨杀跌的风险，或许坚守中线仓位才是真正的智慧。其 二这样的市场环境本身也是相对涨幅较低+安全边际较好+确定性高的主线品类 或较为稀缺，市场流动性又很充裕，因此我们仍建议关注主题投资的机会。 我们于近期的报告《2026 年五大潜在的强主题机会》中提到历史上主题投资活 跃区间多发生在弱基本面和宽流动性时期。当规模以上工业企业利润、宏观经 济景气指数低迷时，叠加流动性上行，主题投资往往处于活跃时期，热门主题 占比相对较高。主题投资的盛行，往往是宏观环境下理智的选择。主题投资的活 跃通常还需要具体的"火种"来点燃，包括技术突破、政策导向、重要事件催化、 赚钱效应及媒体宣传等。筛选强主题的要领在于"买新不买旧，买大不买小"。 回答市场关心的两个问题（1）——中证 500 年内相对弹性强于两端的原因 中证 ...

医药生物 行 业 研 究 2026 年 02 月 01 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -10% 0% 10% 19% 29% 38% 2025-02 2025-06 2025-10 医药生物 沪深300 相关研究报告 《原料药行业价格更新—行业周报》 -2026.1.25 《业绩为王，继续重点推荐创新药产 业链板块性机会 — 行 业 周 报 》 -2026.1.18 | 余汝意（分析师） | 刘艺（联系人） | | --- | --- | | yuruyi@kysec.cn | liuyi1@kysec.cn | | 证书编号：S0790523070002 | 证书编号：S0790124070022 | liuyi1@kysec.cn 证书编号：S0790124070022 中国临床 CRO 行业进入"复苏+稳健增长"新阶段，供需结构持续改善 中国创新药产业已完成从十年前的"离岸外包服务模式"到如今"全球创新资产的 贡献者"的跃迁。临床 CRO 行业在经历 2017–2019 年成长期、2020–2022 年高景气 扩张及 2023–2024 年理性回调后，正进入新一轮复苏与稳定增长 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the emergence of HBN, a leading domestic skincare brand, which has submitted its prospectus to the Hong Kong Stock Exchange, indicating strong growth potential in the efficacy skincare market [3][24] - The report emphasizes the importance of emotional consumption themes and suggests focusing on high-quality companies in high-growth sectors [6][49] Summary by Sections Industry Performance Overview - The commercial retail and social services indices reported declines of 4.18% and 3.45% respectively during the week of January 26 to January 30, 2026, ranking 26th and 23rd among 31 primary industries [5][14] - The jewelry sector showed the highest growth, with a weekly increase of 7.07% and a year-to-date increase of 19.39% [15][18] Key Industry Developments - HBN, established in 2019, is recognized as the largest domestic skincare brand in the efficacy skincare segment, with a market share of 0.8% in the Chinese improvement skincare market as of 2024 [24][25] - HBN's revenue for the first three quarters of 2025 reached 1.51 billion yuan, a year-on-year increase of 10.2%, with high-efficacy skincare products accounting for 78.6% of total revenue [29] Investment Recommendations - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending companies like Laopuhuangjin and Chaohongji [6][49] - Investment Theme 2: Highlighting retail companies that adapt to emotional value and intelligent trends, with recommendations for Yonghui Supermarket and Aiyingshi [6][49] - Investment Theme 3: Emphasizing beauty and personal care brands that innovate with emotional value and safe ingredients, recommending brands like Maogeping and Pola [6][50] - Investment Theme 4: Targeting differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending companies like Aimeike and Meilitiantian [6][51]

2026 年 02 月 01 日 策略研究团队 再提"坚定牛市信心，降低预期斜率" ——投资策略周报 weijixing@kysec.cn 韦冀星（分析师） 耿驰政（联系人） gengchizheng@kysec.cn 证书编号：S0790125050007 波动中仍应坚守仓位 本周市场整体仍处在整理态势中，但板块与个股却有波澜壮阔的极致反馈，如白 酒板块于周中异动大涨，周内成交火热的有色板块于最后一个交易日出现大幅回 撤，给市场带来了一定的恐慌。这也反映出：其一市场频繁且相对极致的轮动表 现很大程度上增加了追涨杀跌的风险，或许坚守中线仓位才是真正的智慧。其 二这样的市场环境本身也是相对涨幅较低+安全边际较好+确定性高的主线品类 或较为稀缺，市场流动性又很充裕，因此我们仍建议关注主题投资的机会。 我们于近期的报告《2026 年五大潜在的强主题机会》中提到历史上主题投资活 跃区间多发生在弱基本面和宽流动性时期。当规模以上工业企业利润、宏观经 济景气指数低迷时，叠加流动性上行，主题投资往往处于活跃时期，热门主题 占比相对较高。主题投资的盛行，往往是宏观环境下理智的选择。主题投资的活 跃通常还需要具体的"火种"来点 ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][5] Core Insights - The company is expected to achieve a net profit attributable to shareholders of approximately 1.67 to 1.85 billion yuan for 2025, representing a year-on-year increase of 54% to 71%. The adjusted net profit is projected to be between 1.62 to 1.79 billion yuan, reflecting a growth of 53% to 69% year-on-year. However, for Q4 2025, the net profit is anticipated to decline by 202% to 45% due to increased income tax and exchange losses [5] - The company has adjusted its profit forecast for 2025-2027, now estimating net profits of 1.759 billion, 2.316 billion, and 2.954 billion yuan respectively, with corresponding EPS of 24.42, 32.15, and 41.00 yuan. The current stock price corresponds to P/E ratios of 21.2, 16.1, and 12.6 times for the respective years [5] - The company is optimistic about the growth of its two-wheeled vehicles and the continued expansion of its brand channels, expecting double-digit growth and stable profitability. The introduction of new products and steady channel expansion in 2026 is also anticipated to contribute to growth [5][7] Financial Summary - For 2025, the company expects total revenue of approximately 21.403 billion yuan, a year-on-year increase of 50.8%. The net profit margin is projected to be 8.2% for 2025, with a gross margin of 30.3% [8] - The company forecasts a revenue growth of 36.1% in 2026, reaching 29.132 billion yuan, and a further increase of 27.4% in 2027, targeting 37.117 billion yuan [8] - The company's return on equity (ROE) is expected to be 22.1% in 2025, increasing to 23.5% in 2026 and stabilizing at 23.4% in 2027 [8] Product Performance - In Q4 2025, the two-wheeled vehicle segment is expected to focus on inventory clearance, with an estimated shipment of 410 million units for the year, and 200,000 to 300,000 units in Q4, reflecting a decline due to policy changes and inventory management [6] - The all-terrain vehicle segment is projected to maintain growth in non-US regions, while the lawn mower robots are expected to exceed expectations due to low inventory levels and seasonal demand [6][7] - For 2026, the two-wheeled vehicle segment is anticipated to outperform industry growth, with a target of 30% volume increase, while the lawn mower robots are expected to see revenue growth double year-on-year [7]

医药生物 行 业 研 究 2026 年 02 月 01 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -10% 0% 10% 19% 29% 38% 2025-02 2025-06 2025-10 医药生物 沪深300 相关研究报告 《原料药行业价格更新—行业周报》 -2026.1.25 《业绩为王，继续重点推荐创新药产 业链板块性机会 — 行 业 周 报 》 -2026.1.18 《减重新靶点初显锋芒，小核酸疗法 前景可期—行业周报》-2026.1.11 供需双改善，国内临床 CRO 行业进入发展新阶段 ——行业周报 | 余汝意（分析师） | 刘艺（联系人） | | --- | --- | | | liuyi1@kysec.cn | | yuruyi@kysec.cn | | | 证书编号：S0790523070002 | 证书编号：S0790124070022 | liuyi1@kysec.cn 证书编号：S0790124070022 中国临床 CRO 行业进入"复苏+稳健增长"新阶段，供需结构持续改善 中国创新药产业已完成从十年前的"离岸外包服务模式"到如今"全球创新资产的 贡献者"的跃迁。临 ...

Group 1 - The report highlights that China's social retail sales are expected to exceed 50 trillion yuan in 2025, reaching 50.1 trillion yuan, with a year-on-year growth of 3.7% [2][10][19] - The contribution of final consumption expenditure to economic growth is projected to be 52%, continuing to act as a main engine for economic development [2][19] - The service consumption sector is becoming the core of growth, with a year-on-year increase of 5.5% in service retail sales and a 4.5% rise in per capita service consumption expenditure, accounting for 46.1% of total per capita consumption expenditure [2][19] Group 2 - The report indicates that the consumption service sector saw a decline of 2.02% this week, while the agriculture, forestry, animal husbandry, and fishery sector experienced a growth of 6.49% [3][31] - Among the listed companies in the consumption service sector, 26% saw an increase in market value, while 74% experienced a decline [3][35] - Notable individual stock performances included Qiu Le Seed Industry (+22.55%), Kang Nong Seed Industry (+13.50%), and Tong Guan Mining Construction (+11.98%) [3][43] Group 3 - As of January 30, 2026, there are 177 companies queued for listing on the North Exchange, with 28 related to the consumption service sector, averaging 1.116 billion yuan in revenue and 129 million yuan in net profit for 2024 [3][45] - Companies such as Shiyang Agricultural Science, Baili Food, and Jule Co. are projected to exceed 200 million yuan in net profit for 2024 [3][45][46] - Sixteen companies in the consumption service sector have announced performance forecasts for 2025, with notable growth expected from Hongyu Packaging, Oufu Egg Industry, Longzhu Technology, and Taihu Snow [3][46][48] Group 4 - The report outlines twelve measures to stimulate service consumption, focusing on six key areas including transportation services, domestic services, online audio-visual services, travel services, automotive aftermarket services, and inbound consumption [10][11] - The report identifies potential growth areas in performance services, sports event services, and emotional/experiential services, with specific companies like Kangbiter, Huayang Racing, and Bixinglong positioned in these sectors [14][15]